HWAM
SNDX icon

Hennion & Walsh Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.5M Buy
342,883
+128,076
+60% +$2.66M 0.21% 108
2026
Q1 		$5.02M Buy
214,807
+31,005
+17% +$674K 0.17% 150
2025
Q4 		$3.86M Buy
183,802
+129,104
+236% +$2.25M 0.13% 194
2025
Q3 		$842K Buy
54,698
+22,513
+70% +$295K 0.03% 554
2025
Q2 		$301K Buy
+32,185
New +$354K 0.01% 811

Other funds holding SNDX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Hennion & Walsh Asset Management's SNDX Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Syndax Pharmaceuticals (SNDX) stake by 60% in Q2 2026, buying an estimated $2.66M and bringing the position to 342,883 shares worth $7.5M. The position accounts for 0.21% of the portfolio, ranked #108.

Hennion & Walsh Asset Management first reported a position in SNDX in Q2 2025 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Hennion & Walsh Asset Management held 342,883 shares of Syndax Pharmaceuticals worth $7.5M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 128,076 Syndax Pharmaceuticals shares in Q2 2026, an estimated $2.66M.
  • Syndax Pharmaceuticals made up 0.21% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #108 holding.
  • Hennion & Walsh Asset Management first reported a position in Syndax Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.